Oragenics Stock Price History
OGEN Stock | USD 1.44 0.06 4.35% |
Below is the normalized historical share price chart for Oragenics extending back to August 11, 2003. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Oragenics stands at 1.44, as last reported on the 23rd of July, with the highest price reaching 1.44 and the lowest price hitting 1.38 during the day.
If you're considering investing in Oragenics Stock, it is important to understand the factors that can impact its price. Oragenics maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the firm had a -0.11 % return per unit of risk over the last 3 months. Oragenics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oragenics' Risk Adjusted Performance of (0.08), variance of 130.91, and Coefficient Of Variation of (978.99) to confirm the risk estimate we provide.
At this time, Oragenics' Common Stock Total Equity is very stable compared to the past year. As of the 23rd of July 2025, Common Stock Shares Outstanding is likely to grow to about 7 M, though Total Stockholder Equity is likely to grow to (201.3 K). . At this time, Oragenics' Price To Sales Ratio is very stable compared to the past year. As of the 23rd of July 2025, Price Sales Ratio is likely to grow to 317.88, while Price Earnings Ratio is likely to drop (0.24). Oragenics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of February 2004 | 200 Day MA 7.4465 | 50 Day MA 3.608 | Beta 0.951 |
Oragenics | Build AI portfolio with Oragenics Stock |
Sharpe Ratio = -0.1133
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | OGEN |
Estimated Market Risk
11.78 actual daily | 96 96% of assets are less volatile |
Expected Return
-1.33 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Oragenics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oragenics by adding Oragenics to a well-diversified portfolio.
Price Book 8.6065 | Enterprise Value Ebitda 0.2113 | Price Sales 89.2791 | Shares Float 629.1 K | Wall Street Target Price 30.003 |
Oragenics Stock Price History Chart
There are several ways to analyze Oragenics Stock price data. The simplest method is using a basic Oragenics candlestick price chart, which shows Oragenics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | April 25, 2025 | 6.0 |
Lowest Price | July 21, 2025 | 1.32 |
Oragenics July 23, 2025 Stock Price Synopsis
Various analyses of Oragenics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Oragenics Stock. It can be used to describe the percentage change in the price of Oragenics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Oragenics Stock.Oragenics Price Daily Balance Of Power | 1.00 | |
Oragenics Price Action Indicator | 0.06 | |
Oragenics Accumulation Distribution | 9,225 | |
Oragenics Price Rate Of Daily Change | 1.04 |
Oragenics July 23, 2025 Stock Price Analysis
Oragenics Stock Price History Data
The price series of Oragenics for the period between Thu, Apr 24, 2025 and Wed, Jul 23, 2025 has a statistical range of 4.68 with a coefficient of variation of 41.5. The daily prices for the period are spread out with arithmetic mean of 4.08. The median price for the last 90 days is 4.37. The company underwent 1:30 stock split on 3rd of June 2025. Oragenics issued dividends to stockholders on 2018-01-22.Open | High | Low | Close | Volume | ||
07/23/2025 | 1.40 | 1.44 | 1.38 | 1.44 | 221,391 | |
07/22/2025 | 1.37 | 1.40 | 1.31 | 1.38 | 165,534 | |
07/21/2025 | 1.39 | 1.39 | 1.31 | 1.32 | 158,000 | |
07/18/2025 | 1.45 | 1.45 | 1.35 | 1.35 | 210,008 | |
07/17/2025 | 1.42 | 1.45 | 1.35 | 1.43 | 281,626 | |
07/16/2025 | 1.35 | 1.45 | 1.30 | 1.42 | 1,045,344 | |
07/15/2025 | 1.40 | 1.41 | 1.31 | 1.34 | 192,470 | |
07/14/2025 | 1.42 | 1.45 | 1.37 | 1.41 | 304,042 | |
07/11/2025 | 1.45 | 1.47 | 1.32 | 1.42 | 311,257 | |
07/10/2025 | 1.42 | 1.49 | 1.41 | 1.46 | 229,183 | |
07/09/2025 | 1.45 | 1.50 | 1.40 | 1.42 | 407,358 | |
07/08/2025 | 1.50 | 1.54 | 1.43 | 1.50 | 692,100 | |
07/07/2025 | 1.55 | 1.57 | 1.39 | 1.54 | 798,238 | |
07/03/2025 | 1.55 | 1.58 | 1.43 | 1.53 | 2,000,600 | |
07/02/2025 | 1.40 | 1.50 | 1.35 | 1.44 | 1,326,300 | |
07/01/2025 | 1.79 | 1.80 | 1.54 | 1.55 | 15,488,500 | |
06/30/2025 | 3.88 | 3.98 | 3.58 | 3.82 | 133,036 | |
06/27/2025 | 3.54 | 4.19 | 3.31 | 4.05 | 305,414 | |
06/26/2025 | 3.56 | 3.88 | 3.31 | 3.49 | 190,541 | |
06/25/2025 | 3.63 | 3.83 | 3.46 | 3.46 | 81,700 | |
06/24/2025 | 3.56 | 3.80 | 3.49 | 3.61 | 46,909 | |
06/23/2025 | 3.62 | 3.66 | 3.41 | 3.56 | 48,478 | |
06/20/2025 | 3.67 | 3.78 | 3.56 | 3.65 | 36,000 | |
06/18/2025 | 4.25 | 4.37 | 3.68 | 3.71 | 82,925 | |
06/17/2025 | 4.85 | 4.85 | 4.28 | 4.37 | 67,894 | |
06/16/2025 | 4.61 | 4.67 | 4.17 | 4.35 | 46,336 | |
06/13/2025 | 4.70 | 4.83 | 4.13 | 4.36 | 80,234 | |
06/12/2025 | 4.68 | 4.88 | 4.42 | 4.63 | 59,900 | |
06/11/2025 | 4.82 | 5.19 | 4.49 | 4.93 | 144,347 | |
06/10/2025 | 4.07 | 4.68 | 4.02 | 4.51 | 78,270 | |
06/09/2025 | 4.12 | 5.24 | 4.02 | 4.33 | 181,718 | |
06/06/2025 | 3.59 | 4.34 | 3.40 | 4.28 | 192,387 | |
06/05/2025 | 3.62 | 3.90 | 3.34 | 3.53 | 209,006 | |
06/04/2025 | 3.53 | 4.00 | 3.12 | 3.70 | 794,837 | |
06/03/2025 | 4.69 | 7.60 | 4.12 | 4.41 | 1,358,300 | |
06/02/2025 | 8.10 | 9.60 | 4.80 | 5.10 | 9,059,057 | |
05/30/2025 | 4.20 | 4.20 | 3.30 | 3.60 | 45,797 | |
05/29/2025 | 3.90 | 4.20 | 3.90 | 3.90 | 40,403 | |
05/28/2025 | 5.40 | 5.40 | 3.90 | 4.20 | 110,477 | |
05/27/2025 | 5.70 | 6.00 | 5.70 | 5.70 | 3,720 | |
05/23/2025 | 5.70 | 5.70 | 5.40 | 5.70 | 4,657 | |
05/22/2025 | 5.70 | 5.70 | 5.70 | 5.70 | 2,127 | |
05/21/2025 | 6.00 | 6.00 | 5.70 | 5.70 | 6,767 | |
05/20/2025 | 6.00 | 6.00 | 5.70 | 6.00 | 7,133 | |
05/19/2025 | 6.00 | 6.00 | 6.00 | 6.00 | 9,583 | |
05/16/2025 | 6.00 | 6.00 | 5.70 | 6.00 | 12,930 | |
05/15/2025 | 5.40 | 6.00 | 5.40 | 5.70 | 11,497 | |
05/14/2025 | 5.70 | 6.60 | 5.70 | 6.00 | 34,293 | |
05/13/2025 | 5.70 | 6.30 | 5.40 | 6.00 | 50,107 | |
05/12/2025 | 5.10 | 5.40 | 5.10 | 5.40 | 11,843 | |
05/09/2025 | 5.40 | 5.70 | 5.10 | 5.10 | 12,163 | |
05/08/2025 | 5.70 | 5.70 | 5.10 | 5.40 | 8,127 | |
05/07/2025 | 5.40 | 5.40 | 4.80 | 5.10 | 11,293 | |
05/06/2025 | 5.40 | 5.40 | 5.10 | 5.40 | 5,437 | |
05/05/2025 | 5.70 | 5.70 | 5.10 | 5.10 | 14,467 | |
05/02/2025 | 6.00 | 6.00 | 5.70 | 5.70 | 7,983 | |
05/01/2025 | 5.70 | 6.00 | 5.70 | 6.00 | 7,033 | |
04/30/2025 | 5.70 | 5.70 | 5.40 | 5.70 | 3,880 | |
04/29/2025 | 6.00 | 6.00 | 5.70 | 5.70 | 4,690 | |
04/28/2025 | 6.00 | 6.30 | 5.70 | 5.70 | 10,440 | |
04/25/2025 | 5.70 | 6.00 | 5.70 | 6.00 | 4,633 |
About Oragenics Stock history
Oragenics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oragenics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oragenics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oragenics stock prices may prove useful in developing a viable investing in Oragenics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 6.6 M | 7 M | |
Net Loss | -12.9 M | -13.5 M |
Oragenics Stock Technical Analysis
Oragenics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
All Next | Launch Module |
Oragenics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oragenics' price direction in advance. Along with the technical and fundamental analysis of Oragenics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oragenics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.08) | |||
Jensen Alpha | (1.47) | |||
Total Risk Alpha | (3.82) | |||
Treynor Ratio | (0.84) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oragenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oragenics. If investors know Oragenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oragenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oragenics is measured differently than its book value, which is the value of Oragenics that is recorded on the company's balance sheet. Investors also form their own opinion of Oragenics' value that differs from its market value or its book value, called intrinsic value, which is Oragenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oragenics' market value can be influenced by many factors that don't directly affect Oragenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oragenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oragenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oragenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.